Medscape39m
Treat-to-Target Approach for RA Improves Time to Pregnancy
More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the ...
emjreviews.com10h
CRISPR Study Reveals Novel Rheumatoid Arthritis Targets: ACR24
NOVEL molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at ...
MedPage Today14h
Is Low Disease Activity Good Enough in RA?
WASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those ...
rheumatologyadvisor16h
Upadacitinib Outperforms Placebo for Treating Giant Cell Arteritis
Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...
FiercePharma20h
With new patient resource to close conversation gaps in rheumatic disease, AbbVie makes 'Rheum for Dialogue'
Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...
gastroenterologyadvisor1d
Distinctive Gut Microbial Composition Seen for Progressors to Rheumatoid Arthritis
Progressors had gut microbiome instability 10 months before RA onset; Prevotellaceae contribute to these changes. HealthDay News — At-risk individuals who progress to rheumatoid arthritis (RA) have a ...